Amphista will be attending and/or presenting at the following conferences. If you would like to meet with us, please email info@amphista.com
https://amphista.com/wp-content/uploads/2021/03/UPS.jpg
800
1000
ginealach
https://amphista.com/wp-content/uploads/2022/03/Amphista_Logo-300x270-1.png
ginealach2020-10-15 14:36:122021-03-16 17:03:31The rise and rise of TPD? Personal highlights from the 3rd Annual TPD Summit 14-15th October 2020
https://amphista.com/wp-content/uploads/2021/03/Microtiter.jpg
800
1000
ginealach
https://amphista.com/wp-content/uploads/2022/03/Amphista_Logo-300x270-1.png
ginealach2020-10-11 14:32:292021-03-16 17:03:45It’s not rocket science
Amphista Therapeutics appoints Dr Victoria Lovatt as Vice President of Intellectual Property
Cambridge, UK – January 30, 2023 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, has announced the appointment of Victoria Lovatt as Vice President of Intellectual Property. Amphista’s CEO Nicola Thompson said, “I am delighted to welcome Victoria as our Vice President of Intellectual Property. Victoria is an IP strategist who […]
Dementia Discovery Fund invests in Amphista Therapeutics as it targets neurodegenerative diseases
Cambridge, UK – December 13, 2022 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced a Series B extension investment by the Dementia Discovery Fund (DDF). The investment is in recognition of the progress made in relation to Amphista’s Eclipsys™ platform and its potential to enable therapies to treat […]
Fierce Biotech Names Amphista Therapeutics as One of its “Fierce 15” Biotech Companies of 2022
Cambridge, UK – September 12, 2022 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced that Fierce Biotech has named it as one of 2022’s Fierce 15 biotechnology companies, designating it as one of the most promising early-stage biotechnology companies in the industry. Amphista is a world leading next-generation […]